Nvidia Is About to Shock the World: October 23rd

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Is The LYFT Finally Heading To The Penthouse? Bullish Momentum Ahead?

Shivank Goswami
September 18, 2025

Lyft (NASDAQ:LYFT) has entered Phase 9 of its 18-phase Adhishthana Cycle, breaking out of its Cakra formation. This move often signals the start of a bullish Himalayan Formation. Here's how the stock is positioned in its cycle and what lies ahead for the stock.

LYFT's Cycle So Far

LYFT has closely moved in line with the Adhishthana Principles across its journey so far. In Phase 2, the stock traded with weak, sluggish behavior during its Sankhya period, but as it moved into the Buddhi period it launched a rally of ~228 percent, exactly as expected.

Fig.1 LYFT Phase 2 (Source: Adhishthana.com)
Fig.1 LYFT’s Phase 2 (Source: Adhishthana.com)

In Phase 3, LYFT created what the framework calls the Yajya formation. The stock traced the arc and fell, in line with Adhishthana expectations.

From Phases 4 through 8, LYFT spent time within its Cakra, a consolidation channel with an arc. This is typically a setup phase before a decisive breakout. On September 15, 2025, as the stock entered Phase 9, it broke out of its Cakra and began rallying. Since then, the stock has already gained about 20 percent.

Fig.2 LYFT Cakra Breakout (Source: Adhishthana.com)
Fig.2 LYFT’s Cakra Breakout (Source: Adhishthana.com)

What Lies Ahead for LYFT?

Phase 9 is often associated with strong rallies under the Adhishthana Principles. This phase runs until May 2026, and the current momentum suggests more upside potential. The rally will eventually lead into a peak in Phase 10, which typically marks the high point of the Himalayan Formation.

Investor Outlook

With a clean breakout from its Cakra, LYFT's ascent looks promising. The stock is already up 20% in Phase 9, and further bullishness appears likely. On the monthly chart, it is also entering its Buddhi period, which reinforces the bullish signal from the weekly cycle. For now, it seems the LYFT may indeed finally be heading to the penthouse.

Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Continue Reading...

Popular

Trump administration puts on hold $18 billion in funding for New York City infrastructure projects

WASHINGTON (AP) — President Donald Trump's administration said Wednesday it was putting a hold on roughly $18 billion to fund beneath the Hudson River between New York City and New Jersey and the city's expanded project because of .

Benzinga Bulls And Bears: Oracle, Costco, NIO — And Wall Street Snaps Its Slide

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

Penguin Solutions Q4 Preview: Modest Beat Likely, Analyst Raises Price Target

Penguin Solutions expected to beat estimates in Q4 due to strong memory demand, according to Rosenblatt analyst. Price target raised.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Trump files $15 billion defamation lawsuit against The New York Times

NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Hit Your Retirement "Freedom Number" (Without $1 Million) - Ad

Retirement should be freedom, not stress. Yet outdated advice and tiny returns leave many trapped. Kelly G. broke free with a revolutionary income strategy once reserved for the wealthy - hitting her "Freedom Number" faster than she dreamed. You might already have enough too.

US To Set $5 Billion Critical Minerals Fund

US to launch $5 billion fund for critical minerals, in partnership with Orion Resource Partners and other investors. Aimed at reducing reliance on Chinese supply chains and securing long-term resources.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

$1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth This Much Today

Alnylam Pharmaceuticals (NASDAQ: ALNY) has outperformed the market over the past 5 years by 10.45% on an annualized basis producing an average annual return of 25.22%. Currently, Alnylam Pharmaceuticals has a market capitalization of $57.78 billion.

Turn Your "Dead Money" Into $306+ Monthly (Starting This Month) - Ad

I've been tracking a financial revolution that most people don't even know exists yet. It lets you generate $306 to $5,000 per month in retirement income... With 10X less money than what financial advisors say you need! This is a new type of investment you can buy with one click in your brokerage account.

Trump Makes Chinese Stocks Great Again — Until Someone Mentions Tariffs

President Donald Trump's recent optimistic remarks on negotiations with China have given a boost to U.S.-listed Chinese stocks. 

Trump and Xi are set to discuss the TikTok deal and future of US-China relations

WASHINGTON (AP) — U.S. is expected to talk with Chinese leader Xi Jinping on Friday in a push to finalize a deal to allow the popular social media app in the United States.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Oracle Surges Over 3% In Pre-Market Amid TikTok Deal Speculation, AI Infrastructure Momentum

Oracle's stock continues to rise, driven by the potential TikTok acquisition and strong AI infrastructure positioning, with a 81.31% gain in 2025.

Benzinga Bulls And Bears: Intel, FedEx, Cracker Barrel — And Markets Close At Record Highs

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

TikTok Stays Online As Trump Extends US Deadline, Washington Still Demands ByteDance Divestment

President Trump said he and Chinese President Xi Jinping made progress on a TikTok deal and will meet in South Korea in just over a month.

FedEx Bets On Cost Cuts To Boost Margins, Says Analyst

FDX shares surge on strong quarterly performance, exceeding revenue and profit expectations. Bank of America raises price forecast to $244.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

$1000 Invested In Federal Signal 10 Years Ago Would Be Worth This Much Today

Federal Signal (NYSE: FSS) has outperformed the market over the past 10 years by 11.38% on an annualized basis producing an average annual return of 24.51%. Currently, Federal Signal has a market capitalization of $7.47 billion.

Hit Your Retirement Income Goal With 10X Less Money - Ad

Financial advisors say you need $1.5M to generate $5,000/month. A revolutionary new investment does it with potentially $150,000. Kelly G: "I updated my spreadsheet and it seems illegal. The income keeps growing." Transform non-dividend stocks like Apple and Tesla into monthly income machines. Bloomberg reports they're "entering a golden era." Simple as buying a stock.

Rivals Compass and Anywhere Real Estate to combine in deal valued at $10 billion including debt

Two of the nation's biggest real estate services companies are combining in a deal that will bring Century 21, Compass and several other major brokerage brands under the same umbrella.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

uCloudlink's GlocalMe Taps Into U.S. Pet Boom With PetPhone After Market Re-Entry

uCloudlink Group's consumer brand GlocalMe is making a renewed push into the U.S. with the launch of PetPhone, an AI-powered device designed to let pets and owners stay connected.

3 Gold Mining Stocks Shine As Prices Hit Records

Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Appeals court rejects Trump's bid to unseat Federal Reserve governor Lisa Cook ahead of rate vote

WASHINGTON (AP) — An appeals court ruled Monday that can remain a Federal Reserve governor, rebuffing President Donald Trump’s efforts to remove her just ahead of a key vote on interest rates.

Toyota and Hyundai recall more than 1.1 million vehicles for seat belt, panel display problems

Toyota and Hyundai are recalling a combined 1.1 million vehicles due to problems with the instrument panel displays and seat belts, U.S. auto regulators said Thursday.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Eric Trump Repeats His $1 Million Prediction For Bitcoin, Foresees An 'Unbelievable' Q4 For Crypto

Eric Trump, the executive vice president of The Trump Organization, expressed his optimism about the future of cryptocurrencies in an interview aired Friday, predicting a surge in the fourth quarter.

Mark Cuban Once Revealed His Favorite Movie Genre Is Apocalypse Chaos — He Even Digged This 'Horrible' Film

Mark Cuban once admitted he's hooked on end-of-the-world movies — even critically panned ones — a quirky obsession that explains his cameo in Sharknado 3.

Hit Your Retirement "Freedom Number" (Without $1 Million) - Ad

Retirement should be freedom, not stress. Yet outdated advice and tiny returns leave many trapped. Kelly G. broke free with a revolutionary income strategy once reserved for the wealthy - hitting her "Freedom Number" faster than she dreamed. You might already have enough too.

FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin

The FDA approved Krystal Biotech's Vyjuvek label update, expanding treatment to newborns and offering flexible wound care based on real-world patient data.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service